000			02397 a2200673 4500
005			20250516004236.0
264		0	_c20110207
008			201102s 0 0 eng d
022			_a2046-4924
024	7		_a10.3310/hta14460-01 _2doi
040			_aNLM _beng _cNLM
100	1		_aWaddington, Cs
245	0	0	_aOpen-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. _h[electronic resource]
260			_bHealth technology assessment (Winchester, England) _cOct 2010
300			_a1-130 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAntibodies, Viral _xbiosynthesis
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDisease Outbreaks _xstatistics & numerical data
650	0	4	_aDrug Combinations
650	0	4	_aEmulsions
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunization Programs
650	0	4	_aInfant
650	0	4	_aInfluenza A Virus, H1N1 Subtype _ximmunology
650	0	4	_aInfluenza Vaccines _xadministration & dosage
650	0	4	_aInfluenza, Human _xprevention & control
650	0	4	_aMale
650	0	4	_aPolysorbates _xadministration & dosage
650	0	4	_aProgram Evaluation
650	0	4	_aSqualene _xadministration & dosage
650	0	4	_aUnited Kingdom
650	0	4	_aalpha-Tocopherol _xadministration & dosage
700	1		_aAndrews, N
700	1		_aHoschler, K
700	1		_aWalker, Wt
700	1		_aOeser, C
700	1		_aReiner, A
700	1		_aJohn, T
700	1		_aWilkins, S
700	1		_aCasey, M
700	1		_aEccleston, Pe
700	1		_aAllen, Rj
700	1		_aOkike, I
700	1		_aLadhani, S
700	1		_aSheasby, E
700	1		_aWaight, P
700	1		_aCollinson, Ac
700	1		_aHeath, Pt
700	1		_aFinn, A
700	1		_aFaust, Sn
700	1		_aSnape, Md
700	1		_aMiller, E
700	1		_aPollard, Aj
773	0		_tHealth technology assessment (Winchester, England) _gvol. 14 _gno. 46 _gp. 1-130
856	4	0	_uhttps://doi.org/10.3310/hta14460-01 _zAvailable from publisher's website
999			_c20229534 _d20229534